Shin, D. W., Kim, M. A., Lee, J., Kim, J., & Hwang, J. (2021). Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients. BMC Res Notes.
Chicago ZitierstilShin, Dong Woo, Minseok Albert Kim, Jong-chan Lee, Jaihwan Kim, und Jin-Hyeok Hwang. "Maintenance of Skeletal Muscle Mass During FOLFIRINOX Is a Favorable Prognostic Factor in Pancreatic Cancer Patients." BMC Res Notes 2021.
MLA ZitierstilShin, Dong Woo, et al. "Maintenance of Skeletal Muscle Mass During FOLFIRINOX Is a Favorable Prognostic Factor in Pancreatic Cancer Patients." BMC Res Notes 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.